Reversibility of alendronate-induced contraction in human osteoclast- like cells formed from bone marrow cells in culture

Journal of Bone and Mineral Metabolism

Volumn 17, Issue 2, 1999, Pages 98-107

  Koshihara, Yasuko ^a   Kodama, Shunji ^a   Ishibashi, Hideaki ^a   Azuma, Yoshiaki ^b   Ohta, Tomohiro ^b   Karube, Shunji ^c  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b TEIJIN LTD   (Japan)

^c Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

Alendronate; Bisphosphonate; Human; Morphology; Osteoclasts

Indexed keywords

ACTIN; ALENDRONIC ACID; PHOSPHONIC ACID DERIVATIVE;

ARTICLE; BONE MARROW CELL; CELL DAMAGE; CELL MOTILITY; CELL SHAPE; CELL SIZE; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERCALCEMIA; MULTINUCLEAR CELL; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

ALENDRONATE; BONE MARROW CELLS; CELL MOVEMENT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OSTEOCLASTS;

EID: 0033001381     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007740050071     Document Type: Article

References (23)

1. Arnett TR, Dempster DW (1987) A comparative study of disaggregated chick and rat osteoclasts in vitro: effect of calcitonin and prostaglandin. Endocrinology 120:602-608
2. Kakudo S, Miyazawa K, Kameda T, Mano H, Mori Y, Yuasa T, Nakamura Y, Shiokawa M, Nagahira K, Tokunaga S, Hakeda Y, Kumegawa M (1996) Isolation of highly enriched rabbit osteoclasts from collagen gels: a new assay system for bone-resorbing activity of mature oseoclasts. J Bone Metab 14:129-136
3. Parfitf AM, Mundy GR, Roodman GD, Hughes DE, Boyce BF (1996) A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J Bone Miner Res 11:150-159
4. Rodan GA, Fleish HA (1996) Bisphosphonates: mechanism of action. J Clin Invest 97:2692-2696
5. Sato M, Grasser W (1990) Effects of bisphosphonate on isolated rat osteoclasts as examined by reflected light microscopy. J Bone Miner Res 5:31-40
6. Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA (1991) Bisphosphonate action: alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88:2095-2105
7. 3H-etidronate in rat and mouse bones. Bone (NY) 19:281-290
8. 3 induces differentiation of osteoclast-like cells from human bone marrow cultures. Biochem Biophys Res Commun 176:1189-1195
9. Tezuka K, Sato T, Kamioka H, Nijweide PJ, Tanaka K, Matsuo T, Ohta M, Kurihara N, Hakeda Y, Kumegawa M (1992) Identification of osteopontin in isolated rabbit osteoclasts. Biochem Biophys Res Commun 186:911-917
10. Kanehisa T, Yamanaka T, Doi S, Turksen K, Heerche JNM, Aubin JE, Takeuchi H (1990) A band of F-actin containing podosomes is involved in bone resorption by osteoclasts. Bone (NY) 11:287-293
11. Davies JE, Shapiro G, Lowenberg BF (1993) Osteoclastic resorption of calcium phosphate ceramic thin film. Cells Mater 3:245-256
12. Carano A, Teitelbaum SL, Konsek JD, Schlesinge PH, Blair HC (1990) Bisphosphonate directly inhibits bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 85:456-461
13. Helfrish MH, Nesbitt SA, Lakkakorpi PT, Barnes MJ, Bodary SC, Shankar G, Mason WT. Mendrick DL, Väänänen HK, Horton MA (1996) B1 integrins and osteoclast function: involvement in collagen recognition and bone resorption. Bone (NY) 19:317-328
14. Suda T, Takahashi N, Martin TJ (1995) Modulation of osteoclast differentiation update. Endocr Rev Monogr 4:266-270
15. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Mosely JM, Martin TJ, Suda T (1988) Osteoblastic cells were involved in osteoclast formation. Endocrinology 123:2600-2602
16. Kurihara N, Chen C, Miller M, Civin C, Roodman GD (1989) Identification of committed mononuclear precursors for osteoclast-like cells formed in long-term human marrow cultures. Endocrinology 126:2733-2740
17. Owens JM, Fuller K, Chambers TJ (1997) Osteoclast activation: potent inhibition by the bisphophonate alendronate through a nonresorptive mechanism. J Cell Physiol 172:79-86
18. Azuma Y, Sato H, Oue Y, Okabe K, Tsuchimoto M, Kiyoki M (1995) Alendronate distribution on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental/ hypercalcemia models. Bone (NY) 16:235-245
19. Schmidt A, Rutledge SJ, Endo N, Opas E, Tanaka H, Wesolowski G, Leu CT, Huang Z, Rmachandaran C, Rodan SB, Rodan GA (1996) Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate. Proc Natl Acad Sci USA 93:3068-3073
20. Opas EE, Rutledge SJ, Golub E, Seern A, Zimolo Z, Rodan GA, Schmidt A (1997) Alendronate inhibition of protein-tyrosine-phosphate-meg-1. Biochem Pharmacol 54:721-727
21. Murakami H, Takahashi N, Tanaka S, Nakamura I, Udagawa N, Nakajo S, Nakaya K, Abe M, Yuda Y, Konno F, Barbier A, Suda T (1997) Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts. Bone (NY) 20:399-404
22. Ito M, Chokki M, Ogino Y, Satomi Y, Azuma Y, Ohta T, Kiyoki M (1998) Comparison of cytotoxic effects of bisphosphonates in vitro and in vivo. Calcif Tissue Int (in press)
23. Murakami H, Takahashi N, Sasaki T, Udagawa N, Tanaka S, Nakamura I, Zhang D, Barbier A, Suda T (1995) A possible mechanism of the specific action of bisphosphonates on osteoclasts: tildronate preferentially affects polarized osteoclasts having ruffled borders. Bone (NY) 17:137-144